Dow Down0.05% Nasdaq Up0.27%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM
12.25 Down 0.05(0.41%) 1:53PM EDT - Nasdaq Real Time Price
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.0
Mean Recommendation (last week):2.0
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:27.50
Median Target:27.50
High Target:30.00
Low Target:25.00
No. of Brokers:2

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Mar 10, 2010HapoalimInitiated Outperform
Dec 9, 2009Jefferies & CoInitiated Buy
Jul 29, 2008Banc of America SecDowngradeBuyNeutral
Jul 29, 2008JP MorganDowngradeOverweightNeutral
Jul 28, 2008Caris & CompanyDowngradeBuyAbove Average
May 2, 2008Caris & CompanyInitiated Buy
Sep 10, 2007Banc of America SecInitiated Buy
May 8, 2007CitigroupInitiated Hold
Feb 14, 2007Friedman BillingsInitiated Outperform
May 23, 2006Thomas WeiselInitiated Outperform

More Upgrades & Downgrades for VNDA

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0001
Buy2222
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.